// App-Quantinova.ai

: EVOLVING LANDSCAPES IN OPTIMAL DURATION OF DUAL ANTIPLATELET THERAPY IN PATIENTS AFTER PCI FOR LEFT MAIN CORONARY DISEASE: INSIGHTS FROM THE LARGEST LM-PCI COHORT

Researchers

Presenter

  • Haoyu Wang

Principal Investigators

  • Bo Xu

  • Kefei Dou

Medical Centers

  • Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Central Nervous System (CNS)

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

Disease

  • Myocardial infarction

  • Venous thrombosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved